China Dasheng Biotechnology Company (CDBT)

Market Cap	2.42M
Revenue (ttm)	20.95M
Net Income (ttm)	6.41M
Shares Out	40.98M
EPS (ttm)	0.21
PE Ratio	0.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,794
Average Volume	11,451
Open	0.0590
Previous Close	0.0590
Day's Range	0.0300 - 0.0590
52-Week Range	0.0003 - 0.0845
Beta	0.52
RSI	51.75
Earnings Date	n/a

About CDBT

China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the benef...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2004
• Employees: 689
• Stock Exchange: OTCMKTS
• Ticker Symbol: CDBT

Financial Performance

In 2008, CDBT's revenue was $16.29 million, an increase of 63.57% compared to the previous year's $9.96 million. Earnings were $4.64 million, an increase of 132.90%.